Biotechnology and the LawAmerican Bar Association, 2007 - 957 lappuses The book is written to help lawyers faced with the challenge of identifying the legal issues and processes that must be faced by their clients in building, marketing, and protecting a biotech business. The contributors are experts in this specialized area and provide thorough, yet accessible, overviews of biotech subspecialties with an eye to practical application. A biotech legal practice involves specialized subject matter and regulatory schemes that, generally, are not part of the business lawyer's repertoire and which can present many hazards for the uninitiated. Because of the expansion in biotech practice beyond the traditional organizations and their representatives, this guide was written to help lawyers find their way through the biotech maze. |
No grāmatas satura
1.5. rezultāts no 68.
xxvi. lappuse
... Established Use " Applications 6. Regulatory Data and Marketing Exclusivity ..... 7. Price Controls and Government Purchasing .......... 8 . Parallel Importation and Parallel Distribution b . Trademark Issues : Repackaging and ...
... Established Use " Applications 6. Regulatory Data and Marketing Exclusivity ..... 7. Price Controls and Government Purchasing .......... 8 . Parallel Importation and Parallel Distribution b . Trademark Issues : Repackaging and ...
xxix. lappuse
... Establishing the Foundation for Trade Secret Protection ............... 864 c . Misappropriation ... Establish a Record of Compliance and Responsibility ..... 868 C. Business Liability ..... 869 1. Corporate Disclosures and Insider ...
... Establishing the Foundation for Trade Secret Protection ............... 864 c . Misappropriation ... Establish a Record of Compliance and Responsibility ..... 868 C. Business Liability ..... 869 1. Corporate Disclosures and Insider ...
xxxii. lappuse
... established , deep - pocketed companies . The expenses involved almost man- date a worldwide marketing strategy involving one or more strategic part- ners . Even after achieving marketing approval , these products can expose their ...
... established , deep - pocketed companies . The expenses involved almost man- date a worldwide marketing strategy involving one or more strategic part- ners . Even after achieving marketing approval , these products can expose their ...
xxxviii. lappuse
... established companies raise capi- tal , acquire and out - license technology , collaborate with strategic partners , and engage in mergers and acquisitions . A graduate of the University of Vir- ginia ( B.A. in 1989 and J.D. in 1994 ) ...
... established companies raise capi- tal , acquire and out - license technology , collaborate with strategic partners , and engage in mergers and acquisitions . A graduate of the University of Vir- ginia ( B.A. in 1989 and J.D. in 1994 ) ...
xxxix. lappuse
... established companies , research and educational in- stitutions , investors , and underwriters in all aspects of the law relating to the protection , enforcement , and transfer of intellectual property rights . He con- centrates on the ...
... established companies , research and educational in- stitutions , investors , and underwriters in all aspects of the law relating to the protection , enforcement , and transfer of intellectual property rights . He con- centrates on the ...
Saturs
IV | 1 |
VI | 4 |
VIII | 5 |
X | 6 |
XII | 7 |
XIV | 8 |
XVI | 9 |
XVIII | 10 |
CDLXXIV | 484 |
CDLXXVI | 485 |
CDLXXVII | 486 |
CDLXXVIII | 487 |
CDLXXIX | 488 |
CDLXXX | 489 |
CDLXXXI | 490 |
CDLXXXIV | 491 |
XX | 11 |
XXIII | 12 |
XXIV | 13 |
XXV | 25 |
XXIX | 26 |
XXXI | 28 |
XXXII | 29 |
XXXIII | 30 |
XXXIV | 31 |
XXXV | 34 |
XXXVI | 35 |
XXXVII | 38 |
XXXVIII | 39 |
XXXIX | 41 |
XL | 42 |
XLI | 43 |
XLII | 45 |
XLIII | 46 |
XLIV | 49 |
XLV | 51 |
XLVI | 52 |
XLVII | 53 |
XLVIII | 57 |
XLIX | 58 |
LI | 60 |
LII | 62 |
LIII | 63 |
LIV | 64 |
LV | 66 |
LVI | 69 |
LVII | 70 |
LVIII | 72 |
LIX | 73 |
LXII | 74 |
LXIII | 75 |
LXVI | 76 |
LXVIII | 77 |
LXX | 78 |
LXXI | 79 |
LXXIII | 80 |
LXXIV | 81 |
LXXV | 82 |
LXXIX | 83 |
LXXXII | 84 |
LXXXIII | 88 |
LXXXV | 91 |
LXXXVI | 95 |
LXXXVIII | 97 |
LXXXIX | 99 |
XCI | 100 |
XCII | 105 |
XCIII | 107 |
XCIV | 108 |
XCV | 109 |
XCVI | 110 |
XCVII | 111 |
XCIX | 112 |
CI | 113 |
CIII | 114 |
CIV | 115 |
CV | 117 |
CVI | 118 |
CVIII | 119 |
CIX | 121 |
CX | 122 |
CXI | 124 |
CXII | 126 |
CXIII | 127 |
CXIV | 132 |
CXV | 139 |
CXVIII | 140 |
CXX | 141 |
CXXI | 142 |
CXXII | 143 |
CXXIV | 145 |
CXXVI | 146 |
CXXVII | 147 |
CXXVIII | 148 |
CXXIX | 149 |
CXXX | 150 |
CXXXII | 151 |
CXXXIV | 152 |
CXXXVI | 154 |
CXXXVIII | 155 |
CXLI | 156 |
CXLIII | 158 |
CXLV | 160 |
CXLVII | 161 |
CXLVIII | 162 |
CXLIX | 168 |
CL | 169 |
CLI | 170 |
CLII | 171 |
CLIV | 172 |
CLVI | 173 |
CLVII | 174 |
CLVIII | 175 |
CLXI | 176 |
CLXVIII | 177 |
CLXXII | 178 |
CLXXVIII | 179 |
CLXXXIII | 180 |
CLXXXIV | 183 |
CLXXXVI | 184 |
CLXXXVIII | 185 |
CXC | 186 |
CXCII | 187 |
CXCV | 188 |
CXCVII | 189 |
CCII | 190 |
CCIV | 191 |
CCVI | 192 |
CCIX | 193 |
CCXIII | 194 |
CCXVIII | 195 |
CCXXII | 196 |
CCXXIII | 197 |
CCXXVII | 198 |
CCXXVIII | 199 |
CCXXX | 203 |
CCXXXI | 204 |
CCXXXIII | 206 |
CCXXXIV | 209 |
CCXXXV | 210 |
CCXXXVII | 212 |
CCXXXVIII | 213 |
CCXXXIX | 214 |
CCXLI | 215 |
CCXLIII | 216 |
CCXLIV | 217 |
CCXLV | 218 |
CCXLVII | 219 |
CCXLIX | 220 |
CCL | 221 |
CCLII | 222 |
CCLIV | 223 |
CCLVII | 224 |
CCLIX | 225 |
CCLXI | 226 |
CCLXIII | 227 |
CCLXIV | 228 |
CCLXVII | 230 |
CCLXIX | 231 |
CCLXX | 232 |
CCLXXII | 233 |
CCLXXIII | 234 |
CCLXXV | 235 |
CCLXXVII | 236 |
CCLXXVIII | 237 |
CCLXXIX | 239 |
CCLXXXI | 240 |
CCLXXXII | 241 |
CCLXXXIV | 253 |
CCLXXXV | 265 |
CCLXXXVI | 266 |
CCLXXXVII | 267 |
CCLXXXVIII | 268 |
CCLXXXIX | 270 |
CCXC | 271 |
CCXCI | 272 |
CCXCIII | 273 |
CCXCV | 274 |
CCXCVIII | 275 |
CCCII | 276 |
CCCIV | 277 |
CCCVII | 281 |
CCCX | 282 |
CCCXIII | 283 |
CCCXIV | 285 |
CCCXVI | 286 |
CCCXVII | 287 |
CCCXX | 288 |
CCCXXIII | 289 |
CCCXXVII | 290 |
CCCXXIX | 291 |
CCCXXXI | 299 |
CCCXXXIII | 300 |
CCCXXXIV | 301 |
CCCXXXVII | 302 |
CCCXXXIX | 303 |
CCCXLII | 304 |
CCCXLIV | 305 |
CCCXLVI | 307 |
CCCXLVII | 308 |
CCCXLVIII | 309 |
CCCXLIX | 310 |
CCCL | 312 |
CCCLII | 314 |
CCCLIV | 315 |
CCCLV | 318 |
CCCLVI | 325 |
CCCLVII | 326 |
CCCLVIII | 327 |
CCCLIX | 328 |
CCCLX | 330 |
CCCLXII | 331 |
CCCLXIV | 332 |
CCCLXVI | 337 |
CCCLXVII | 340 |
CCCLXVIII | 342 |
CCCLXIX | 344 |
CCCLXXI | 345 |
CCCLXXII | 346 |
CCCLXXIII | 347 |
CCCLXXIV | 348 |
CCCLXXVI | 349 |
CCCLXXVIII | 350 |
CCCLXXIX | 351 |
CCCLXXXI | 352 |
CCCLXXXIV | 353 |
CCCLXXXVII | 354 |
CCCLXXXIX | 356 |
CCCXC | 358 |
CCCXCI | 407 |
CCCXCII | 408 |
CCCXCV | 411 |
CCCXCVI | 412 |
CCCXCVII | 415 |
CCCXCVIII | 417 |
CCCXCIX | 418 |
CD | 419 |
CDI | 420 |
CDII | 421 |
CDIII | 422 |
CDIV | 423 |
CDV | 424 |
CDVIII | 425 |
CDIX | 433 |
CDX | 434 |
CDXII | 438 |
CDXIII | 439 |
CDXIV | 441 |
CDXV | 442 |
CDXVII | 445 |
CDXVIII | 446 |
CDXIX | 449 |
CDXX | 450 |
CDXXI | 451 |
CDXXII | 452 |
CDXXIII | 453 |
CDXXV | 454 |
CDXXVI | 455 |
CDXXVII | 456 |
CDXXXI | 457 |
CDXXXIV | 458 |
CDXXXVII | 459 |
CDXXXIX | 460 |
CDXLII | 461 |
CDXLIV | 462 |
CDXLVI | 463 |
CDXLIX | 464 |
CDLI | 465 |
CDLIII | 469 |
CDLVI | 470 |
CDLVIII | 471 |
CDLIX | 472 |
CDLXI | 475 |
CDLXIV | 476 |
CDLXVII | 477 |
CDLXVIII | 479 |
CDLXIX | 480 |
CDLXX | 481 |
CDLXXIII | 483 |
CDLXXXVI | 493 |
CDLXXXVII | 494 |
CDLXXXVIII | 495 |
CDLXXXIX | 497 |
CDXCI | 498 |
CDXCII | 499 |
CDXCIV | 500 |
CDXCVII | 501 |
CDXCVIII | 509 |
CDXCIX | 512 |
DI | 518 |
DII | 519 |
DIII | 521 |
DV | 523 |
DVI | 524 |
DVII | 525 |
DVIII | 526 |
DIX | 528 |
DXII | 529 |
DXV | 530 |
DXVII | 531 |
DXVIII | 532 |
DXIX | 534 |
DXXI | 536 |
DXXIII | 537 |
DXXIV | 539 |
DXXVIII | 542 |
DXXIX | 543 |
DXXX | 544 |
DXXXI | 545 |
DXXXII | 546 |
DXXXIII | 547 |
DXXXV | 549 |
DXXXVII | 550 |
DXXXVIII | 551 |
DXL | 552 |
DXLI | 553 |
DXLIII | 554 |
DXLVIII | 555 |
DL | 563 |
DLI | 564 |
DLIII | 565 |
DLV | 566 |
DLVI | 567 |
DLVIII | 568 |
DLIX | 569 |
DLX | 571 |
DLXI | 574 |
DLXIII | 576 |
DLXIV | 578 |
DLXV | 579 |
DLXVII | 580 |
DLXIX | 581 |
DLXXI | 582 |
DLXXII | 583 |
DLXXIII | 586 |
DLXXV | 587 |
DLXXVI | 588 |
DLXXVII | 591 |
DLXXVIII | 592 |
DLXXIX | 593 |
DLXXXI | 595 |
DLXXXIII | 596 |
DLXXXIV | 597 |
DLXXXV | 600 |
DLXXXVII | 602 |
DLXXXIX | 603 |
DXC | 605 |
DXCII | 607 |
DXCIII | 608 |
DXCIV | 609 |
DXCV | 610 |
DXCVIII | 612 |
DXCIX | 614 |
DC | 615 |
DCI | 623 |
DCII | 625 |
DCIII | 627 |
DCIV | 628 |
DCV | 629 |
DCVI | 630 |
DCVII | 631 |
DCVIII | 632 |
DCXI | 633 |
DCXIII | 635 |
DCXIV | 636 |
DCXV | 637 |
DCXVI | 639 |
DCXVII | 641 |
DCXVIII | 642 |
DCXX | 643 |
DCXXI | 644 |
DCXXIV | 645 |
DCXXVII | 646 |
DCXXIX | 647 |
DCXXX | 648 |
DCXXXI | 661 |
DCXXXII | 662 |
DCXXXIII | 664 |
DCXXXIV | 666 |
DCXXXV | 668 |
DCXXXVI | 670 |
DCXXXIX | 671 |
DCXLI | 672 |
DCXLIII | 673 |
DCXLIV | 674 |
DCXLV | 677 |
DCXLVI | 679 |
DCXLVIII | 680 |
DCXLIX | 682 |
DCL | 683 |
DCLII | 684 |
DCLIII | 686 |
DCLV | 687 |
DCLVI | 691 |
DCLX | 692 |
DCLXI | 693 |
DCLXII | 694 |
DCLXIV | 695 |
DCLXV | 696 |
DCLXVI | 699 |
DCLXVIII | 700 |
DCLXIX | 701 |
DCLXXI | 707 |
DCLXXII | 708 |
DCLXXIV | 709 |
DCLXXV | 710 |
DCLXXIX | 711 |
DCLXXXI | 712 |
DCLXXXIV | 713 |
DCLXXXV | 714 |
DCLXXXVI | 715 |
DCLXXXVII | 716 |
DCLXXXIX | 718 |
DCXC | 721 |
DCXCI | 722 |
DCXCII | 723 |
DCXCIV | 724 |
DCXCVII | 725 |
DCXCVIII | 726 |
DCXCIX | 728 |
DCCI | 729 |
DCCIII | 730 |
DCCV | 731 |
DCCVI | 732 |
DCCVII | 733 |
DCCVIII | 735 |
DCCXIII | 737 |
DCCXIV | 739 |
DCCXVI | 740 |
DCCXVII | 741 |
DCCXVIII | 742 |
DCCXXI | 743 |
DCCXXIII | 744 |
DCCXXIV | 745 |
DCCXXVI | 746 |
DCCXXVIII | 747 |
DCCXXIX | 748 |
DCCXXX | 749 |
DCCXXXI | 750 |
DCCXXXIII | 751 |
DCCXXXV | 753 |
DCCXXXVII | 755 |
DCCXXXVIII | 756 |
DCCXL | 757 |
DCCXLII | 758 |
DCCXLIII | 759 |
DCCXLIV | 761 |
DCCXLV | 762 |
DCCXLVI | 763 |
DCCXLVIII | 764 |
DCCLI | 765 |
DCCLII | 766 |
DCCLIII | 767 |
DCCLVI | 768 |
DCCLVII | 769 |
DCCLX | 771 |
DCCLXII | 772 |
DCCLXIII | 773 |
DCCLXV | 774 |
DCCLXVI | 775 |
DCCLXVII | 776 |
DCCLXIX | 777 |
DCCLXXI | 779 |
DCCLXXII | 780 |
DCCLXXIV | 781 |
DCCLXXVI | 782 |
DCCLXXIX | 783 |
DCCLXXXII | 784 |
DCCLXXXIII | 785 |
DCCLXXXIV | 786 |
DCCLXXXV | 787 |
DCCLXXXVI | 788 |
DCCLXXXIX | 789 |
DCCXC | 790 |
DCCXCI | 791 |
DCCXCIII | 792 |
DCCXCV | 793 |
DCCXCVIII | 794 |
DCCXCIX | 795 |
DCCCI | 796 |
DCCCV | 797 |
DCCCVI | 798 |
DCCCVIII | 813 |
DCCCIX | 815 |
DCCCX | 816 |
DCCCXII | 817 |
DCCCXIII | 818 |
DCCCXIV | 819 |
DCCCXVII | 821 |
DCCCXVIII | 822 |
DCCCXIX | 824 |
DCCCXX | 825 |
DCCCXXI | 826 |
DCCCXXII | 828 |
DCCCXXIII | 829 |
DCCCXXIV | 830 |
DCCCXXV | 831 |
DCCCXXVI | 833 |
DCCCXXVII | 834 |
DCCCXXVIII | 835 |
DCCCXXIX | 836 |
DCCCXXXI | 837 |
DCCCXXXII | 838 |
DCCCXXXIII | 840 |
DCCCXXXIV | 841 |
DCCCXXXV | 843 |
DCCCXXXVII | 857 |
DCCCXXXVIII | 858 |
DCCCXXXIX | 859 |
DCCCXLII | 863 |
DCCCXLIV | 864 |
DCCCXLV | 865 |
DCCCXLVI | 866 |
DCCCXLVII | 867 |
DCCCXLVIII | 868 |
DCCCL | 869 |
DCCCLI | 870 |
DCCCLIII | 871 |
DCCCLV | 872 |
DCCCLVI | 873 |
DCCCLVIII | 874 |
DCCCLX | 875 |
DCCCLXI | 880 |
DCCCLXIV | 881 |
DCCCLXVII | 882 |
DCCCLXX | 883 |
DCCCLXXI | 884 |
DCCCLXXIII | 885 |
DCCCLXXIV | 886 |
DCCCLXXVI | 887 |
DCCCLXXVII | 888 |
DCCCLXXVIII | 893 |
DCCCLXXIX | 894 |
DCCCLXXX | 896 |
DCCCLXXXI | 900 |
DCCCLXXXIII | 912 |
DCCCLXXXIV | 918 |
DCCCLXXXVI | 923 |
DCCCLXXXVII | 933 |
935 | |
Citi izdevumi - Skatīt visu
Biotechnology and the Law Hugh B. Wellons,Robert F. Copple,Bill Wofford Priekšskatījums nav pieejams - 2020 |
Bieži izmantoti vārdi un frāzes
addition agency agreement amended animal drugs approval authorization Bayh-Dole Act biological product biotech company biotechnology biotechnology company cell chapter claims clinical trials collaboration commercial company's compliance conduct confidentiality contract contractor Covered Entity disclose disclosure documents employee ensure European European Commission European Medicines Agency exemption FDA's federal filing founders funding genetic GMOs grant Guidance hazardous waste HIPAA human IACUC individual infringement Initial Public Offering intellectual property invention investigational investors issues license licensor limited litigation manufacturing medical devices Medicare medicinal products ment option organization parties partner patent application payment pharmaceutical pharmacovigilance potential Practice Points preclinical research prior art Privacy procedures protection registration regulations regulatory requirements risk royalty safety shares specific sponsor tion trade secret trademark VSTA